201 related articles for article (PubMed ID: 28393626)
1. In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors.
Mahapatra MK; Bera K; Singh DV; Kumar R; Kumar M
J Biomol Struct Dyn; 2018 Apr; 36(5):1195-1211. PubMed ID: 28393626
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and in silico studies of 5-(3-methoxybenzylidene)thiazolidine-2,4-dione analogues as PTP1B inhibitors.
Mahapatra MK; Kumar R; Kumar M
Bioorg Chem; 2017 Apr; 71():1-9. PubMed ID: 28126289
[TBL] [Abstract][Full Text] [Related]
3. In silico investigations on the binding efficacy and allosteric mechanism of six different natural product compounds towards PTP1B inhibition through docking and molecular dynamics simulations.
SarathKumar B; Lakshmi BS
J Mol Model; 2019 Aug; 25(9):272. PubMed ID: 31451955
[TBL] [Abstract][Full Text] [Related]
4. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
5. Computer-Aided Strategy on 5-(Substituted benzylidene) Thiazolidine-2,4-Diones to Develop New and Potent PTP1B Inhibitors: QSAR Modeling, Molecular Docking, Molecular Dynamics, PASS Predictions, and DFT Investigations.
Derki NH; Kerassa A; Belaidi S; Derki M; Yamari I; Samadi A; Chtita S
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398573
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J
Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040
[TBL] [Abstract][Full Text] [Related]
7. A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.
Tripuraneni NS; Azam MA
J Biomol Struct Dyn; 2016 Nov; 34(11):2481-92. PubMed ID: 26587754
[TBL] [Abstract][Full Text] [Related]
8. Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations.
Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J
J Biomol Struct Dyn; 2018 Nov; 36(14):3636-3650. PubMed ID: 29048995
[TBL] [Abstract][Full Text] [Related]
9. A Library of Thiazolidin-4-one Derivatives as Protein Tyrosine Phosphatase 1B (PTP1B) Inhibitors: An Attempt To Discover Novel Antidiabetic Agents.
Patel AD; Pasha TY; Lunagariya P; Shah U; Bhambharoliya T; Tripathi RKP
ChemMedChem; 2020 Jul; 15(13):1229-1242. PubMed ID: 32390300
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore modeling, 3D-QSAR, and docking study of pyrozolo[1,5-a]pyridine/4,4-dimethylpyrazolone analogues as PDE4 selective inhibitors.
Tripuraneni NS; Azam MA
J Mol Model; 2015 Nov; 21(11):289. PubMed ID: 26499496
[TBL] [Abstract][Full Text] [Related]
11. Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor/acceptor groups of the molecule and docking analysis: An application on the discovery of novel effective PTP1B inhibitors.
Eleftheriou P; Petrou A; Geronikaki A; Liaras K; Dirnali S; Anna M
SAR QSAR Environ Res; 2015; 26(7-9):557-76. PubMed ID: 26294069
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore generation, atom-based 3D-QSAR and molecular dynamics simulation analyses of pyridine-3-carboxamide-6-yl-urea analogues as potential gyrase B inhibitors.
Azam MA; Thathan J
SAR QSAR Environ Res; 2017 Apr; 28(4):275-296. PubMed ID: 28399673
[TBL] [Abstract][Full Text] [Related]
13. An amalgamated molecular dynamic and Gaussian based 3D-QSAR study for the design of 2,4-thiazolidinediones as potential PTP1B inhibitors.
Biharee A; Singh Y; Kulkarni S; Jangid K; Kumar V; Jain AK; Thareja S
J Mol Graph Model; 2024 Mar; 127():108695. PubMed ID: 38118354
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics approach to probe the allosteric inhibition of PTP1B by chlorogenic and cichoric acid.
Baskaran SK; Goswami N; Selvaraj S; Muthusamy VS; Lakshmi BS
J Chem Inf Model; 2012 Aug; 52(8):2004-12. PubMed ID: 22747429
[TBL] [Abstract][Full Text] [Related]
15. Validation of formylchromane derivatives as protein tyrosine phosphatase 1B inhibitors by pharmacophore modeling, atom-based 3D-QSAR and docking studies.
Malla P; Kumar R; Kumar M
Chem Biol Drug Des; 2013 Jul; 82(1):71-80. PubMed ID: 23506477
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.
Aouidate A; Ghaleb A; Ghamali M; Ousaa A; Choukrad M; Sbai A; Bouachrine M; Lakhlifi T
Comput Biol Chem; 2018 Jun; 74():201-211. PubMed ID: 29635214
[TBL] [Abstract][Full Text] [Related]
17. Molecular Dynamics Simulations of A27S and K120A Mutated PTP1B Reveals Selective Binding of the Bidentate Inhibitor.
Chen X; Liu X; Gan Q; Feng C; Zhang Q
Biomed Res Int; 2019; 2019():9852897. PubMed ID: 30729132
[TBL] [Abstract][Full Text] [Related]
18. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
Halder AK; Saha A; Saha KD; Jha T
J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
[TBL] [Abstract][Full Text] [Related]
19. Computational Insight into Protein Tyrosine Phosphatase 1B Inhibition: A Case Study of the Combined Ligand- and Structure-Based Approach.
Zhang X; Jiang H; Li W; Wang J; Cheng M
Comput Math Methods Med; 2017; 2017():4245613. PubMed ID: 29441120
[TBL] [Abstract][Full Text] [Related]
20. Integrated use of ligand and structure-based virtual screening, molecular dynamics, free energy calculation and ADME prediction for the identification of potential PTP1B inhibitors.
Devi B; Vasishta SS; Das B; Baidya ATK; Rampa RS; Mahapatra MK; Kumar R
Mol Divers; 2024 Apr; 28(2):649-669. PubMed ID: 36745307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]